Patents by Inventor Janshon Zhu

Janshon Zhu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINED DEVICE FOR LIQUID-PHASE MASS SPECTROMETRY SAMPLING AND ELECTROSPRAY
    Publication number: 20230204547
    Abstract: The present disclosure is applicable to the field of analytical instruments, and provides a multifunctional probe for sample pickup, delivery and electrospray ionization used for direct sample analysis with a liquid-phase mass spectrometer. The multifunctional probe comprises a needle body and a tip part, wherein said tip part is continuously contracted from the needle body in whole or in part, and said tip part is provided with a solution carrying structure. The present disclosure further provides a combined sample introduction and electrospray device for liquid-phase mass spectrometry comprising said multifunctional probe, further comprising a mechanical arm and an ion source with a sealed chamber and a needle port on the sealed chamber.
    Type: Application
    Filed: March 7, 2023
    Publication date: June 29, 2023
    Inventor: Janshon ZHU
  • Pseudo internal standard method, device and application for mass spectrometry quantitative analysis
    Patent number: 10643829
    Abstract: A pseudo internal standard method, device and application for mass spectrometry quantitative analysis is disclosed.
    Type: Grant
    Filed: August 30, 2016
    Date of Patent: May 5, 2020
    Assignee: GUANGDONG LIANJIE BIOTECHNOLOGY CO., LTD.
    Inventor: Janshon Zhu
  • PSEUDO INTERNAL STANDARD METHOD, DEVICE AND APPLICATION FOR MASS SPECTROMETRY QUANTITATIVE ANALYSIS
    Publication number: 20180269047
    Abstract: A pseudo internal standard method, device and application for mass spectrometry quantitative analysis is disclosed.
    Type: Application
    Filed: August 30, 2016
    Publication date: September 20, 2018
    Inventor: Janshon ZHU
  • Transmucosal taxane composition
    Patent number: 9572790
    Abstract: The present invention provides a pharmaceutical composition for delivering an active agent taxane through transmucosal administration, more particularly through the buccal mucosa or sublingual mucosa. The present invention provides a method for treating cancer by buccal or sublingual administration of the pharmaceutical composition to a subject. The pharmaceutical composition comprises a taxane, a non-ionic surfactant, a viscosity enhancing agent, an adhesive agent, and an alcohol solvent at pH 4-6.
    Type: Grant
    Filed: April 17, 2015
    Date of Patent: February 21, 2017
    Assignee: XIAMEN LP PHARMACEUTICAL CO., LTD.
    Inventors: Ying Ye, Janshon Zhu
  • TRANSMUCOSAL TAXANE COMPOSITION
    Publication number: 20150297554
    Abstract: The present invention provides a pharmaceutical composition for delivering an active agent taxane through transmucosal administration, more particularly through the buccal mucosa or sublingual mucosa. The present invention provides a method for treating cancer by buccal or sublingual administration of the pharmaceutical composition to a subject. The pharmaceutical composition comprises a taxane, a non-ionic surfactant, a viscosity enhancing agent, an adhesive agent, and an alcohol solvent at pH 4-6.
    Type: Application
    Filed: April 17, 2015
    Publication date: October 22, 2015
    Inventors: Ying YE, Janshon Zhu
  • Transmucosal administration of taxanes
    Patent number: 9018246
    Abstract: The present invention provides a pharmaceutical composition for delivering an active agent taxane through transmucosal administration, more particularly through the buccal mucosa or sublingual mucosa. The present invention provides a method for treating cancer by buccal or sublingual administration of the pharmaceutical composition to a subject. The pharmaceutical composition comprises a taxane, a non-ionic surfactant, a viscosity enhancing agent, an adhesive agent, and an alcohol solvent at pH 4-6.
    Type: Grant
    Filed: September 5, 2012
    Date of Patent: April 28, 2015
    Assignee: LP Pharmaceutical (Xiamen) Co., Ltd.
    Inventors: Ying Ye, Janshon Zhu
  • TRANSMUCOSAL ADMINISTRATION OF TAXANES
    Publication number: 20140066495
    Abstract: The present invention provides a pharmaceutical composition for delivering an active agent taxane through transmucosal administration, more particularly through the buccal mucosa or sublingual mucosa. The present invention provides a method for treating cancer by buccal or sublingual administration of the pharmaceutical composition to a subject. The pharmaceutical composition comprises a taxane, a non-ionic surfactant, a viscosity enhancing agent, an adhesive agent, and an alcohol solvent at pH 4-6.
    Type: Application
    Filed: September 5, 2012
    Publication date: March 6, 2014
    Inventors: Ying YE, Janshon Zhu